Peel Hunt is acting as Bookrunner, joint Corporate Broker and NOMAD to Shield Therapeutics plc on a US$6.1m Equity fundraise (comprising a subscription and placing) with a concurrent Rex Retail Offer (for an additional up to US$1.4m), as announced on 28th September, 2023.
